Certain Common Stock of KalVista Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 15-APR-2024. These Common Stock will be under lockup for 61 days starting from 14-FEB-2024 to 15-APR-2024.

Details:
Officers and directors have agreed, subject to specified customary exceptions, not to, without prior written consent of the representatives, directly or indirectly sell, offer, contract or grant any option to sell (including any short sale), pledge, transfer, establish an open ?put equivalent position? within the meaning of Rule 16a-1(h) under the Securities Exchange Act of 1934, as amended, or otherwise dispose of any shares of common stock, options or warrants to acquire shares of common stock, or securities exchangeable or exercisable for or convertible into shares of common stock currently or hereafter owned either of record or beneficially, or publicly announce an intention to do any of the foregoing for a period of 60 days after the date of this prospectus supplement in the case of officers and directors.